Recent Finacing
Recent Raise
bit.bio is a Cambridge-based biotech that programs human induced pluripotent stem cells into highly pure, scalable cell products for research, drug discovery and toxicology applications.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at bit.bio.
